Andrew, J.G., Andrew, S.M., Ash, A., and Turner, B. (1991). An investigation into the role of
inflammatory cells in Dupuytren's disease. J. Hand Surg. Br. 16, 267-271.
Arima, Y., Harada, M., Kamimura, D., Park, J.H., Kawano, F., Yull, F.E., Kawamoto, T., Iwakura,
Y., Betz, U.A., Marquez, G., et al. (2012). Regional neural activation defines a gateway for
autoreactive T cells to cross the blood-brain barrier. Cell 148, 447-457.
Arima, Y., Kamimura, D., Atsumi, T., Harada, M., Kawamoto, T., Nishikawa, N., Stofkova, A.,
Ohki, T., Higuchi, K., Morimoto, Y., et al. (2015). A pain-mediated neural signal induces relapse
in murine autoimmune encephalomyelitis, a multiple sclerosis model. Elife 4, 1-23.
Arima, Y., Ohki, T., Nishikawa, N., Higuchi, K., Ota, M., Tanaka, Y., Nio-Kobayashi, J., Elfeky,
M., Sakai, R., Mori, Y., et al. (2017). Brain micro-inflammation at specific vessels dysregulates
organ-homeostasis via the activation of a new neural circuit. Elife 6, 1-27
Atsumi, T., Singh, R., Sabharwal, L., Bando, H., Meng, J., Arima, Y., Yamada, M., Harada, M.,
Jiang, J.J., Kamimura, D., et al. (2014). Inflammation amplifier, a new paradigm in cancer biology.
Cancer Res. 74, 8-14.
Atsumi, T., Suzuki, H., Jiang, J.J., Okuyama, Y., Nakagawa, I., Ota, M., Tanaka, Y., Ohki, T.,
Katsunuma, K., Nakajima, K., et al. (2017). Rbm10 regulates inflammation development via
alternative splicing of Dnmt3b. Int. Immunol. 29, 581-591.
Bazin, S., Le Lous, M., Duance, V.C., Sims, T.J., Bailey, A.J., Gabbiani, G., D'Andiran, G.,
Pizzolato, G., Browski, A., Nicoletis, C., and Delaunay, A. (1980). Biochemistry and histology of
the connective tissue of Dupuytren's disease lesions. Eur. J. Clin. Invest. 10, 9-16.
Becker, K., Tinschert, S., Lienert, A., Bleuler, P.E., Staub, F., Meinel, A., Rossler, J., Wach, W.,
Hoffmann, R., Kuhnel, F., et al. (2015). The importance of genetic susceptibility in Dupuytren's
disease. Clin. Genet. 87, 483-487.
Becker, K., Siegert, S., Toliat, M.R., Du, J., Casper, R., Dolmans, G.H., Werker, P.M., Tinschert,
S., Franke, A., Gieger, C., et al. (2016). Meta-Analysis of Genome-Wide Association Studies and
52
Network Analysis-Based Integration with Gene Expression Data Identify New Suggestive Loci
and Unravel a Wnt-Centric Network Associated with Dupuytren's Disease. PLoS One 11,
Bianchi, E., Taurone, S., Bardella, L., Signore, A., Pompili, E., Sessa, V., Chiappetta, C.,
Fumagalli, L., Di Gioia, C., Pastore, F.S., et al. (2015). Involvement of pro-inflammatory
cytokines and growth factors in the pathogenesis of Dupuytren's contracture: a novel target for a
possible future therapeutic strategy? Clin. Sci. (Lond.) 129, 711-720.
Brickley-Parsons, D., Glimcher, M.J., Smith, R.J., Albin, R., and Adams, J.P. (1981). Biochemical
changes in the collagen of the palmar fascia in patients with Dupuytren's disease. J. Bone Joint
Surg. Am. 63, 787-797.
Burge, S.K., Amodei, N., Elkin, B., Catala, S., Andrew, S.R., Lane, P.A., and Seale, J.P. (1997).
An evaluation of two primary care interventions for alcohol abuse among Mexican-American
patients. Addiction 92, 1705-1716.
Capstick, R., Bragg, T., Giele, H., and Furniss, D. (2013). Sibling recurrence risk in Dupuytren's
disease. J. Hand Surg. Eur. Vol. 38, 424-429.
Descatha, A., Jauffret, P., Chastang, J.F., Roquelaure, Y., and Leclerc, A. (2011). Should we
consider Dupuytren's contracture as work-related? A review and meta-analysis of an old debate.
BMC Musculoskelet. Disord. 12, 96.
Dolmans, G.H., Werker, P.M., Hennies, H.C., Furniss, D., Festen, E.A., Franke, L., Becker, K.,
van der Vlies, P., Wolffenbuttel, B.H., Tinschert, S., et al. (2011). Wnt signaling and Dupuytren's
disease. N. Engl. J. Med. 365, 307-317.
Feldman, G., Rozen, N., and Rubin, G. (2017). Dupuytren's Contracture: Current Treatment
Methods. Isr. Med. Assoc. J. 19, 648-650.
Fujita, M., Yamamoto, Y., Jiang, J.J., Atsumi, T., Tanaka, Y., Ohki, T., Murao, N., Funayama, E.,
Hayashi, T., Osawa, M., et al. (2019). NEDD4 Is Involved in Inflammation Development during
Keloid Formation. J. Invest. Dermatol. 139, 333-341.
Ghosh, S., and Hayden, M.S. (2008). New regulators of NF-kappaB in inflammation. Nat. Rev.
53
Immunol. 8, 837-848.
Godtfredsen, N.S., Lucht, H., Prescott, E., Sorensen, T.I., and Gronbaek, M. (2004). A prospective
study linked both alcohol and tobacco to Dupuytren's disease. J. Clin. Epidemiol. 57, 858-863.
Gudmundsson, K.G., Arngrimsson, R., Sigfusson, N., Bjornsson, A., and Jonsson, T. (2000).
Epidemiology of Dupuytren's disease: clinical, serological, and social assessment. The Reykjavik
Study. J. Clin. Epidemiol. 53, 291-296.
Harada, M., Kamimura, D., Arima, Y., Kohsaka, H., Nakatsuji, Y., Nishida, M., Atsumi, T., Meng,
J., Bando, H., Singh, R., et al. (2015). Temporal expression of growth factors triggered by
epiregulin regulates inflammation development. J. Immunol. 194, 1039-1046.
Higuchi, H., Kamimura, D., Jiang, J.J., Atsumi, T., Iwami, D., Hotta, K., Harada, H., Takada, Y.,
Kanno-Okada, H., Hatanaka, K.C., et al. (2020). Orosomucoid 1 is involved in the development
of chronic allograft rejection after kidney transplantation. Int. Immunol. 32, 335-346.
Izadi, D., Layton, T.B., Williams, L., McCann, F., Cabrita, M., Espirito Santo, A.I., Xie, W.,
Fritzsche, M., Colin-York, H., Feldmann, M., et al. (2019). Identification of TNFR2 and IL-33 as
therapeutic targets in localized fibrosis. Sci Adv 5, 1-12.
Kanada, S., Nishiyama, C., Nakano, N., Suzuki, R., Maeda, K., Hara, M., Kitamura, N., Ogawa,
H., and Okumura, K. (2011). Critical role of transcription factor PU.1 in the expression of CD80
and CD86 on dendritic cells. Blood 117, 2211-2222.
Kloen, P. (1999). New insights in the development of Dupuytren's contracture: a review. Br. J.
Plast. Surg. 52, 629-635.
Krause, C., Kloen, P., and Ten Dijke, P. (2011). Elevated transforming growth factor beta and
mitogen-activated protein kinase pathways mediate fibrotic traits of Dupuytren's disease
fibroblasts. Fibrogenesis Tissue Repair 4, 14.
Lanting, R., Broekstra, D.C., Werker, P.M.N., and van den Heuvel, E.R. (2014). A systematic
review and meta-analysis on the prevalence of Dupuytren disease in the general population of
Western countries. Plast. Reconstr. Surg. 133, 593-603.
54
Larsen, S., Krogsgaard, D.G., Aagaard Larsen, L., Iachina, M., Skytthe, A., and Frederiksen, H.
(2015). Genetic and environmental influences in Dupuytren's disease: a study of 30,330 Danish
twin pairs. J. Hand Surg. Eur. Vol. 40, 171-176.
Lee, J., Nakagiri, T., Oto, T., Harada, M., Morii, E., Shintani, Y., Inoue, M., Iwakura, Y., Miyoshi,
S., Okumura, M., et al. (2012). IL-6 amplifier, NF-kappaB-triggered positive feedback for IL-6
signaling, in grafts is involved in allogeneic rejection responses. J. Immunol. 189, 1928-1936.
Lee, J., Nakagiri, T., Kamimura, D., Harada, M., Oto, T., Susaki, Y., Shintani, Y., Inoue, M.,
Miyoshi, S., Morii, E., et al. (2013). IL-6 amplifier activation in epithelial regions of bronchi after
allogeneic lung transplantation. Int. Immunol. 25, 319-332.
Ling, R.S. (1963). The Genetic Factor in Dupuytren's Disease. J. Bone Joint Surg. Br. 45, 709718.
Liss, G.M., and Stock, S.R. (1996). Can Dupuytren's contracture be work-related?: review of the
evidence. Am. J. Ind. Med. 29, 521-532.
Meek, R.M., McLellan, S., and Crossan, J.F. (1999). Dupuytren's disease. A model for the
mechanism of fibrosis and its modulation by steroids. J. Bone Joint Surg. Br. 81, 732-738.
Meng, J., Jiang, J.J., Atsumi, T., Bando, H., Okuyama, Y., Sabharwal, L., Nakagawa, I., Higuchi,
H., Ota, M., Okawara, M., et al. (2016). Breakpoint Cluster Region-Mediated Inflammation Is
Dependent on Casein Kinase II. J. Immunol. 197, 3111-3119.
Miller, J.R. (2002). The Wnts. Genome Biol. 3, 1-15.
Murakami, M., Okuyama, Y., Ogura, H., Asano, S., Arima, Y., Tsuruoka, M., Harada, M.,
Kanamoto, M., Sawa, Y., Iwakura, Y., et al. (2011). Local microbleeding facilitates IL-6- and IL17-dependent arthritis in the absence of tissue antigen recognition by activated T cells. J. Exp.
Med. 208, 103-114.
Murakami, M., Harada, M., Kamimura, D., Ogura, H., Okuyama, Y., Kumai, N., Okuyama, A.,
Singh, R., Jiang, J.J., Atsumi, T., et al. (2013). Disease-association analysis of an inflammationrelated feedback loop. Cell Rep. 3, 946-959.
55
Murakami, M., Kamimura, D., and Hirano, T. (2019). Pleiotropy and Specificity: Insights from
the Interleukin 6 Family of Cytokines. Immunity 50, 812-831.
Narimatsu, M., Maeda, H., Itoh, S., Atsumi, T., Ohtani, T., Nishida, K., Itoh, M., Kamimura, D.,
Park, S.J., Mizuno, K., et al. (2001). Tissue-specific autoregulation of the stat3 gene and its role
in interleukin-6-induced survival signals in T cells. Mol. Cell. Biol. 21, 6615-6625.
Ng, M., Thakkar, D., Southam, L., Werker, P., Ophoff, R., Becker, K., Nothnagel, M., Franke, A.,
Nurnberg, P., Espirito-Santo, A.I., et al. (2017). A Genome-wide Association Study of Dupuytren
Disease Reveals 17 Additional Variants Implicated in Fibrosis. Am. J. Hum. Genet. 101, 417-427.
Ogura, H., Murakami, M., Okuyama, Y., Tsuruoka, M., Kitabayashi, C., Kanamoto, M.,
Nishihara, M., Iwakura, Y., and Hirano, T. (2008). Interleukin-17 promotes autoimmunity by
triggering a positive-feedback loop via interleukin-6 induction. Immunity 29, 628-636.
Okuyama, Y., Tanaka, Y., Jiang, J.J., Kamimura, D., Nakamura, A., Ota, M., Ohki, T., Higo, D.,
Ogura, H., Ishii, N., et al. (2018). Bmi1 Regulates IkappaBalpha Degradation via Association
with the SCF Complex. J. Immunol. 201, 2264-2272.
Ota, M., Tanaka, Y., Nakagawa, I., Jiang, J.J., Arima, Y., Kamimura, D., Onodera, T., Iwasaki, N.,
and Murakami, M. (2020). Role of Chondrocytes in the Development of Rheumatoid Arthritis
Via Transmembrane Protein 147-Mediated NF-kappaB Activation. Arthritis Rheumatol 72, 931942.
Pawar, N.M., and Rao, P. (2018). Secreted frizzled related protein 4 (sFRP4) update: A brief
review. Cell. Signal. 45, 63-70.
Shimoyama, S., Nakagawa, I., Jiang, J.J., Matsumoto, I., Chiorini, J.A., Hasegawa, Y., Ohara, O.,
Hasebe, R., Ota, M., Uchida, M., et al. (2021). Sjogren's syndrome-associated SNPs increase
GTF2I expression in salivary gland cells to enhance inflammation development. Int. Immunol.
33, 423-434.
Stofkova, A., Kamimura, D., Ohki, T., Ota, M., Arima, Y., and Murakami, M. (2019). Photopic
light-mediated down-regulation of local alpha(1A)-adrenergic signaling protects blood-retina
56
barrier in experimental autoimmune uveoretinitis. Sci. Rep. 9, 1-15.
Takada, Y., Kamimura, D., Jiang, J.J., Higuchi, H., Iwami, D., Hotta, K., Tanaka, Y., Ota, M.,
Higuchi, M., Nishio, S., et al. (2020). Increased urinary exosomal SYT17 levels in chronic active
antibody-mediated rejection after kidney transplantation via the IL-6 amplifier. Int. Immunol. 32,
653-662.
Tanaka, Y., Sabharwal, L., Ota, M., Nakagawa, I., Jiang, J.J., Arima, Y., Ogura, H., Okochi, M.,
Ishii, M., Kamimura, D., and Murakami, M. (2018). Presenilin 1 Regulates NF-kappaB
Activation via Association with Breakpoint Cluster Region and Casein Kinase II. J. Immunol.
201, 2256-2263.
Tanaka, H., Arima, Y., Kamimura, D., Tanaka, Y., Takahashi, N., Uehata, T., Maeda, K., Satoh,
T., Murakami, M., and Akira, S. (2019). Phosphorylation-dependent Regnase-1 release from
endoplasmic reticulum is critical in IL-17 response. J. Exp. Med. 216, 1431-1449.
Verjee, L.S., Verhoekx, J.S., Chan, J.K., Krausgruber, T., Nicolaidou, V., Izadi, D., Davidson, D.,
Feldmann, M., Midwood, K.S., and Nanchahal, J. (2013). Unraveling the signaling pathways
promoting fibrosis in Dupuytren's disease reveals TNF as a therapeutic target. Proc. Natl. Acad.
Sci. U. S. A. 110, E928-937.
Wilburn, J., McKenna, S.P., Perry-Hinsley, D., and Bayat, A. (2013). The impact of Dupuytren
disease on patient activity and quality of life. J. Hand Surg. Am. 38, 1209-1214.
Wynn, T.A., and Ramalingam, T.R. (2012). Mechanisms of fibrosis: therapeutic translation for
fibrotic disease. Nat. Med. 18, 1028-1040.
57
...
論文の公開元へ
